21 May 2009
Algorithm of clinical protocol lowering the risk of systemic mycosis infections
E Swoboda-Kopeć, I Netsvyetayeva, L Pączek, A Kwiatkowski, M Pacholczyk, G Młynarczyk, M Łuczak, E Mierzwińska-Nastalska, M Sikora, S Błachnio, P FiedorAnn Transplant 2009; 14(1): 71-71 :: ID: 880462
Abstract
The aim of the study was to elaborate diagnostic protocol scheme lowering the
risk of mycotic invasive infection in allotransplant recipients and to propose
introduction of pre-operative prophylaxis and/or empirical therapy.
Material/Methods: The following clinical samples were examined: blood samples, swabs taken from mouth lesions, throat swabs, rectal swabs, sputum, urine and faecal samples taken from a chosen group of kidney transplant recipients (KTx) and simultaneous pancreas and kidney transplantation (SPKTx) recipients highly predisposed to mycotic infections, which were treated in Hospital - Lindley'a Campus at Warsaw Medical University between 2003 and 2006. Conventional fungal laboratory diagnosis, enzymatic activity tests, serological tests, molecular diagnosis of samples taken from the sterile body sites and histopathological examinations were used.
Results: A group of 268 allograft recipients either with transient or constant yeast colonisation or with confirmed yeast infection was chosen. There were 7744 clinical samples analysed and among them 475 were positive for fungi. Microbiologic criteria of diagnosing systemic mycosis and principles of distinction between colonization and infection were established.
Conclusions: Prophylaxis and/or empirical therapy, culture-guided therapy was elaborated. To introduce this in clinical practice the quality and effectiveness were evaluated (including costs of diagnosis and treatment).
Keywords: fungal infections
In Press
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860